Ocular Surface Changes in Primary Open Angle Glaucoma Patients Treated With Topical Antihypertensive Drugs

被引:2
|
作者
Castro, Catarina [1 ,4 ]
Marta, Ana [1 ,2 ]
Marques, Joao H. [1 ]
Ferreira, Andre [1 ,3 ]
Jose, Diana [1 ]
Sousa, Paulo [1 ]
Neves, Isabel [1 ]
Meneres, Maria Joao [1 ,2 ]
Barbosa, Irene [1 ,2 ]
机构
[1] Univ Porto, Ctr Hosp Univ St Antonio, Dept Ophthalmol, Porto, Portugal
[2] Univ Porto, Inst Biomed Sci Abel Salazar, Dept Ophthalmol, Porto, Portugal
[3] Univ Porto, Dept Biomed, Unit Anat, Fac Med, Porto, Portugal
[4] Ctr Hosp Univ Porto, Dept Ophthalmol, P-4099001 Porto, Portugal
关键词
glaucoma; ocular surface; dry eye disease; QUALITY-OF-LIFE; DRY EYE SYNDROME; INTRAOCULAR-PRESSURE; DISEASE;
D O I
10.1097/IJG.0000000000002272
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Precis: In this study, patients with glaucoma undergoing topical antihypertensive (TAH) drugs had changes in the ocular surface and more dry eye symptoms than controls. Clinicians should recognize the influence of TAH drops on exacerbating ocular surface disease.Purpose: The purpose of this study was to evaluate the ocular surface of eyes with glaucoma treated with TAH drugs.Methods: Cross-sectional study that included eyes undergoing TAH drugs due to primary open angle glaucoma and controls. The parameters evaluated were: the basal tear flow (basic secretion test); the tear film osmolarity (TearLab); and the noninvasive break-up time, blink score, lipid layer thickness, tear meniscus height, and loss area of the meibomian glands, measured with the IDRA Ocular Surface Analyser. Presence of symptoms [Ocular Surface Disease Index (OSDI)], dry eye disease (DED, TFOS DEWS II criteria), and corneal fluorescein staining were assessed.Results: We included 154 eyes (154 patients), 77 undergoing TAH drugs for glaucoma (group 1) and 77 of controls (group 2). The tear film osmolarity (P=0.003) and the loss area of the meibomian glands (P=0.004) were higher in group 1. The noninvasive break-up time (P=0.005), lipid layer thickness (P=0.006), and tear meniscus height (P=0.001) were lower in group 1. The global OSDI score (P<0.001), the proportion of eyes with severe disease (P=0.002), according to the OSDI, and with DED (P<0.001), according to the TFOS DEWS II criteria, were higher in group 1. The proportion of patients with corneal fluorescein staining was higher in group 1 (P<0.001). There were no significant differences in eyes taking TAH drugs with and without preservatives (P>0.127).Conclusions: DED, in patients with glaucoma, is a multifactorial disease, with a strong contribution from TAH drugs. These eyes had changes in almost every measured parameter, translating into the presence of more dry eye symptoms and corneal damage when compared with controls.
引用
收藏
页码:E113 / E120
页数:8
相关论文
共 50 条
  • [21] The pulsatile ocular flow in primary open angle glaucoma patients undergoing trabeculectomy
    Fan, DP
    Fu, ZF
    Zhang, MZ
    Liu, XR
    Wu, XB
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [22] Potentials of OCT in Monitoring Ocular Hemodynamics of Patients with Primary Open Angle Glaucoma
    Iomdina, E. N.
    Khoziev, D. D.
    Kiseleva, A. A.
    Luzhnov, P., V
    Kiseleva, O. A.
    Shamaev, D. M.
    XV MEDITERRANEAN CONFERENCE ON MEDICAL AND BIOLOGICAL ENGINEERING AND COMPUTING - MEDICON 2019, 2020, 76 : 390 - 396
  • [23] Adherence to Ocular Hypotensive Medication in Patients With Primary Open Angle Glaucoma in Ghana
    Kyei, Samuel
    Kwao, Eric
    Mashige, Percy Khathutshelo
    Abu, Sampson Listowell
    Racette, Lyne
    JOURNAL OF GLAUCOMA, 2023, 32 (09) : 777 - 782
  • [24] Pharmacotherapy Compliance in Patients with Ocular Hypertension or Primary Open-Angle Glaucoma
    Traverso, Carlo E.
    Walt, John G.
    Stern, Lee S.
    Dolgitser, Margarita
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2009, 25 (01) : 77 - 82
  • [25] Functional parameters in patients with ocular hypertension and primary open-angle glaucoma
    Salomone, Mariella
    Verboschi, Francesca
    Fragiotta, Serena
    Valente, Stefano
    Domanico, Daniela
    Spadea, Leopoldo
    Vingolo, Enzo M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [26] Ocular Hemodynamic Changes after Trabeculectomy in Pseudoexfoliative and Primary Open-Angle Glaucoma
    Diliene, Vaida
    Harris, Alon
    Januleviciene, Ingrida
    Siaudvytyte, Lina
    Barsauskaite, Ruta
    Siesky, Brent
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [27] Changes in ocular morphology after cataract surgery in open angle glaucoma patients
    Pakuliene, Giedre
    Kuzmiene, Loreta
    Siesky, Brent
    Harris, Alon
    Januleviciene, Ingrida
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [28] Changes in ocular morphology after cataract surgery in open angle glaucoma patients
    Giedre Pakuliene
    Loreta Kuzmiene
    Brent Siesky
    Alon Harris
    Ingrida Januleviciene
    Scientific Reports, 11
  • [29] Comparative Efficacy and Tolerability of Topical Prostaglandin Analogues for Primary Open-Angle Glaucoma and Ocular Hypertension
    Lin, Liang
    Zhao, Ying Jiao
    Chew, Paul T. K.
    Sng, Chelvin C. A.
    Wong, Hon-Tym
    Yip, Leonard W.
    Wu, Tuck Seng
    Bautista, Dianne
    Teng, Monica
    Khoo, Ai Leng
    Lim, Boon Peng
    ANNALS OF PHARMACOTHERAPY, 2014, 48 (12) : 1585 - 1593
  • [30] Effectiveness and Safety of Topical Bimatoprost Insert for Primary Open-Angle Glaucoma and Ocular Hypertension Treatment
    Cronemberger, Sebastiao
    Franca, Jucara R.
    Faria Araujo, Alan Cezar
    da Cunha, Francine Rubiao
    Gomes Faraco, Andre Augusto
    Ferreira, Anderson
    Foureaux, Giselle
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)